Navigation Links
Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
Date:10/22/2007

SWARTZ CREEK, Mich., Oct. 22 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Atheer A. Kaddis has joined the company's executive management team. Dr. Kaddis will serve as Vice President of Managed Markets for the company. He reports directly to Diplomat Specialty Pharmacy's President and CEO, Philip Hagerman.

"The addition of Atheer Kaddis offers Diplomat the Managed Care expertise we need to further develop competitive, cost saving specialty programs making us an attractive choice for health care plans," comments Hagerman. "Atheer's wealth of knowledge in the managed care arena will be invaluable to us as we continue to expand nationally."

Dr. Kaddis stated, "I believe that Diplomat Specialty Pharmacy is a great organization that has made a commitment to help its patients, providers, and customers navigate the complexities of specialty pharmacy in order to provide access to cost-effective, high quality care. I am very excited to be a part of the Diplomat Specialty Pharmacy team."

Before joining Diplomat, Dr. Kaddis worked for Blue Cross Blue Shield of Michigan (BCBSM) as their Director of Pharmacy Services-Clinical. As the Director of Pharmacy Services-Clinical, Dr. Kaddis was responsible for the development and implementation of the specialty pharmacy program, development of the prescription drug formulary, development of clinical pharmacy programs, drug information, provider education, and customer liaison activities. Dr. Kaddis' previous experience also includes the position of Associate Director, Clinical Services at Merck-Medco. Dr. Kaddis is a graduate of the Doctor of Pharmacy program at Wayne State University in Detroit, Michigan.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns

Executive Assistant

Diplomat Specialty Pharmacy

810.720.4452

kkarns@diplomatpharmacy.com


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Charter and Berbee connect Pharmacy Cooperative
2. Germantown drug company hires pharma veteran James Davidson as COO
3. Merge Healthcare hires new VP of finance
4. PDS hires new VP, buys former health club building
5. Siemens health services president calls IT benefits unassailable
6. Wisconsin IT association names Gee president, CEO
7. Merge Healthcare promotes Bowers to president
8. Quintessence Biosciences names new president
9. VanderSanden appointed president of AT&T Wisconsin
10. Merge president steps down in wake of shareholder suits
11. Milwaukees PointOne appoints new president and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Eurofins announces the appointment ... and President of Eurofins Scientific Inc. (ESI). Mr. ... his proven professional and entrepreneurial experience in leading international business teams. ... US food testing market to uphold Eurofins, status as the global ... ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
(Date:12/8/2016)... 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing and commercializing products to treat rare diseases ... today the long-term follow-up data from its Phase ... Innate Defense Regulator (IDR), in the treatment of ... patients undergoing chemoradiation therapy (CRT).  The additional 12-month ...
(Date:12/8/2016)... -- Partnering to fuel Philadelphia,s innovative ... Southeastern Pennsylvania (" Ben Franklin "); ... Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... million funding initiative over a four year period to ... a burgeoning economic vitality in digital health, Ben ...
Breaking Biology Technology:
(Date:12/5/2016)... WASHINGTON , Dec. 5, 2016  The ... (NIJ), today published "Can CT Scans Enhance or ... examines the potential of supporting or replacing forensic ... a CT scan. In response to ... NIJ is exploring using CT scans as a ...
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/22/2016)... India , November 22, 2016 According to ... (Fingerprint, IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and ... 2022", published by MarketsandMarkets, the market is expected to grow from USD ... a CAGR of 16.79% between 2016 and 2022. ... ...
Breaking Biology News(10 mins):